Innate Pharma S.A. (IPHA)
NASDAQ: IPHA
· Real-Time Price · USD
2.25
0.04 (1.58%)
At close: May 02, 2025, 11:42 AM
Innate Pharma S.A. Revenue
Innate Pharma S.A. reported an annual revenue of $51.9M, reflecting a 4.56% growth. For the quarter ending June 30, 2024, Innate Pharma S.A. generated $12.35M in revenue.
Revenue (ttm)
$51.9M
Revenue Growth
4.56%
Price / Sales Ratio
4.11
Revenue / Employee
$286.75K
Employees
181
Market Cap
188.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|